Related Experiment Videos
Predictors of response to divalproex and lithium
1Department of Psychiatry, University of Texas Health Science Center, San Antonio 78284.
The Journal of Clinical Psychiatry
|January 1, 1995
Summary
Identifying predictors of mood stabilizer response helps psychiatrists choose treatments for bipolar disorder. Lithium is best for mild, uncomplicated cases, while divalproex and carbamazepine suit more complex presentations.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Neuroscience
Background:
- Predicting patient response to mood stabilizers is crucial for effective psychiatric treatment.
- Optimizing medication selection ensures prompt symptom improvement and minimizes adverse effects.
Purpose of the Study:
- To review predictors of response to mood stabilizers like lithium, divalproex, and carbamazepine.
- To guide clinicians in selecting appropriate mood stabilizers based on patient characteristics.
Main Methods:
- Literature review of studies on mood stabilizer response predictors.
- Analysis of clinical features associated with differential drug efficacy.
Main Results:
- Lithium response is predicted by mild, uncomplicated illness, pure mania, prior response, and infrequent episodes.
- Divalproex benefits a broader range of patients, including those with mixed mania, rapid cycling, substance abuse, and secondary bipolar disorder.
- Carbamazepine may be effective for lithium non-responders, particularly in combination therapy.
Conclusions:
- While definitive predictors are limited, combining known features with patient status aids treatment selection.
- Personalized pharmacotherapy for bipolar disorder can be improved by understanding these response patterns.